Amarjot Kaur
Rajpura, PB, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Transforming advancing autosomal dominant polycystic kidney disease care: investigating new horizons in treatment and research.
Journal: Inflammopharmacology
Published: July 01, 2025
Nicotine Dependence-Induced Withdrawal Syndrome: Mechanistic Insights and Therapeutic Implications.
Journal: CNS & neurological disorders drug targets
Published: January 24, 2025
Insights into therapeutic approaches for the treatment of neurodegenerative diseases targeting metabolic syndrome.
Journal: Molecular biology reports
Published: August 01, 2024
Diabetic Cardiomyopathy: An Update on Emerging Pathological Mechanisms.
Journal: Current cardiology reviews
Published: May 20, 2024
Exploring therapeutic potential: Targeting TRPM7 in neurodegenerative diseases.
Journal: International immunopharmacology
Published: May 16, 2024
Proposed Hypothesis of TWEAK/Fn14 Receptor Modulation in Autism Spectrum Disorder.
Journal: CNS & neurological disorders drug targets
Published: May 14, 2024
Coexistence of BCR::ABL1 translocation and JAK2V617F mutations in indian patients with myeloproliferative neoplasms: A case series.
Journal: Indian journal of pathology & microbiology
Published: March 29, 2024
Primary Uterine Alveolar Soft Part Sarcoma in a Postmenopausal Woman: Histopathologic and Immunohistochemical Characteristics of a Rare Case.
Journal: International journal of surgical pathology
Published: December 12, 2023
Cytological spectrum of testicular malignancies with histopathological correlation: A retrospective analysis.
Journal: Diagnostic cytopathology
Published: June 19, 2023
Liposarcoma of tongue: A case report.
Journal: Indian journal of pathology & microbiology
Published: June 03, 2023
Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration.
Journal: Pharmacological reports : PR
Published: May 24, 2023
SGK-1 Signalling Pathway is a Key Factor in Cell Survival in Ischemic Injury.
Journal: Current drug targets
Published: December 02, 2022
Last Updated: 09/26/2026